Public signalCompany raiseAuto-indexed · Unverified
GT Biopharma, Inc. is raising up to $20.0M
GT Biopharma, Inc.· SAN FRANCISCO, US· Biotechnology· Filed May 28, 2025
GT Biopharma, Inc. has announced an offering and is seeking capital. No amount is confirmed as raised. Based in SAN FRANCISCO, CALIFORNIA, US. First sale reported 2025-05-14. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Seeking up to
$20.0M
Target — nothing confirmed as raised
Confidence60%
On the record
- Location
- SAN FRANCISCO, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Announced target
- Target amount
- $20.0M
- Filing date
- May 28, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Sources & provenance
“Reg D offering of up to 20,000,000 USD filed; nothing reported sold yet.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated May 28, 2025. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnologyCompany Raise
Are you associated with GT Biopharma, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record